146 related articles for article (PubMed ID: 15675579)
1. [The second-line chemotherapy for urological cancers].
Miki T; Mikami K; Mizutani Y
Gan To Kagaku Ryoho; 2005 Jan; 32(1):33-8. PubMed ID: 15675579
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma.
Matsumoto K; Irie A; Satoh T; Okazaki M; Iwamura M; Baba S
Int J Urol; 2007 Nov; 14(11):1000-4; discussion 1004. PubMed ID: 17956525
[TBL] [Abstract][Full Text] [Related]
3. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S
Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707
[TBL] [Abstract][Full Text] [Related]
4. Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP).
Kim KH; Hong SJ; Han KS
BMC Cancer; 2015 Oct; 15():812. PubMed ID: 26506914
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy and radiotherapy for urological cancer].
Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
[TBL] [Abstract][Full Text] [Related]
6. [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].
Lehmann J; Retz M; Steiner G; Albers P; Jaeger E; Knuth A; Lippert C; Koser M; Stockamp K; Otto C; Melchior H; Fassmann C; Potratz C; Loch T; Derigs HG; Becker T; Kälble T; Piechota HJ; Hertle L; Weinknecht S; Weissbach L; Al-Mwalad M; Hamza A; Henss H; Brkovic D; Pomer S; Roloff J; Walz P; Muschter R; Tunn U; Winter E; Bub P; Kaldenbach U; Roth S; Brauers A; Jakse G; Richter AE; Wirth M; Hartlapp J; Van Ahlen H; Stöckle M
Urologe A; 2003 Aug; 42(8):1074-86. PubMed ID: 14513232
[TBL] [Abstract][Full Text] [Related]
7. [Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)].
Ochi T; Ozawa A; Tanji N; Yanagihara Y; Yanagaki T; Miyauchi Y; Ikeda T; Shimamoto K; Toshino A; Sugawara T; Hamada H; Yokoyama M
Nihon Hinyokika Gakkai Zasshi; 2006 Sep; 97(6):777-81. PubMed ID: 17025209
[TBL] [Abstract][Full Text] [Related]
8. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
[TBL] [Abstract][Full Text] [Related]
9. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for urothelial infiltrating tumors].
Culine S
Cancer Radiother; 1998; 2(5):515-20. PubMed ID: 9868395
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Farmakis D; Pectasides M; Pectasides D
Eur Urol; 2005 Sep; 48(3):400-7. PubMed ID: 15964136
[TBL] [Abstract][Full Text] [Related]
12. What news in urological cancer.
Lorusso V
Tunis Med; 2005 Dec; 83 Suppl 12():75-6. PubMed ID: 16430074
[No Abstract] [Full Text] [Related]
13. Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract.
Bajorin DF
Eur J Cancer; 2000 Jul; 36 Suppl 2():26-9. PubMed ID: 10908845
[TBL] [Abstract][Full Text] [Related]
14. [Recent progress in the treatment for urothelial cancer].
Koga H; Naito S
Gan To Kagaku Ryoho; 2006 Feb; 33(2):164-70. PubMed ID: 16484850
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant chemotherapy for urothelial tumors].
Culine S
Rev Prat; 2014 Dec; 64(10):1399. PubMed ID: 25665321
[No Abstract] [Full Text] [Related]
16. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
17. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
Hsieh MC; Chiang PH; Rau KM; Chen YY; Su YL; Huang CH
Urol Oncol; 2015 Nov; 33(11):495.e9-495.e14. PubMed ID: 26254698
[TBL] [Abstract][Full Text] [Related]
18. Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).
Matsui Y; Ogawa O; Ishitsuka R; Miyazaki J; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Fujie K; Keino N; Nishiyama H
Int J Clin Oncol; 2016 Dec; 21(6):1142-1149. PubMed ID: 27349431
[TBL] [Abstract][Full Text] [Related]
19. [Progress in therapy for testicular tumors].
Mizutani Y; Nakamura T; Nomoto T; Kawauchi A; Miki T
Gan To Kagaku Ryoho; 2006 Feb; 33(2):183-7. PubMed ID: 16484853
[TBL] [Abstract][Full Text] [Related]
20. The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers.
Matsui Y; Nishiyama H; Yoshimura K; Xing ND; Sumiyoshi T; Saito R; Inoue T; Kamba T; Ogawa O
Int J Clin Oncol; 2013 Apr; 18(2):321-8. PubMed ID: 22410820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
